Aberrant LDHA and LDHB expression due to hypomethylation of the promoter and the resulting increased lactate concentration are involved in acquired TAM resistance in breast cancer cells (Hamadneh et al., 2021). This evidence concerns the gene LDHA and breast carcinoma.